Biotech Stocks: Time to Worry
August 26, 2014 at 14:29 PM EDT
Remember when the biotech world was falling apart? Neither do we. I mean, just look at these returns: Gilead Sciences (GILD) has gained 41% so far this year as investors appear to have put their Sovaldi worries behind them; InterMune (ITMN) has quintupled in 2014 after Roche agreed to purchase it for $8.3 billion; and [...]
